2,663
Views
5
CrossRef citations to date
0
Altmetric
Article

Vitamin D levels in IBD: a randomised trial of weight-based versus fixed dose vitamin D supplementation

ORCID Icon, , , , , , & show all
Pages 671-676 | Received 08 Jan 2020, Accepted 23 May 2020, Published online: 13 Jun 2020

References

  • Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):1717S–1720S.
  • Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases. JPEN J Parent Enteral Nutr. 2014;38(3):385–391.
  • Narula N, Marshall JK. Management of inflammatory bowel disease with vitamin D: beyond bone health. J Crohns Colitis. 2012;6(4):397–404.
  • Gose M, Krems C, Heuer T, et al. Trends in food consumption and nutrient intake in Germany between 2006 and 2012: results of the German National Nutrition Monitoring (NEMONIT). Br J Nutr. 2016;115(8):1498–1507.
  • Institute of Medicine (US). Committee to review dietary reference intakes for vitamin D and calcium. Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US); 2011.
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Dietary reference values for vitamin D. EFSA J. 2016;10: 4.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Endocrine Society, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
  • Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, European Crohn’s and Colitis Organisation [ECCO], et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
  • Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–755.
  • Zittermann A, Ernst JB, Gummert JF, et al. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr. 2014;53(2):367–374.
  • Ekwaru JP, Zwicker JD, Holick MF, et al. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS ONE. 2014;9(11):e111265.
  • Forsythe LK, Livingstone MBE, Barnes MS, et al. Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br J Nutr. 2012;107(1):126–134.
  • Gallagher JC, Sai A, Templin T, et al. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156(6):425–437.
  • Heaney RP, Armas LA, Shary JR, et al. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87(6):1738–1742.
  • Freeman J, Wilson K, Spears R, et al. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2. Clin Biochem. 2015;48(16-17):1097–1104.
  • Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196–1199.
  • Jungert A, Roth HJ, Neuhäuser-Berthold M. Serum 25-hydroxyvitamin D3 and body composition in an elderly cohort from Germany: a cross-sectional study. Nutr Metab (Lond). 2012;9(1):42.
  • Camozzi V, Frigo AC, Zaninotto M, et al. 25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese. Osteoporos Int. 2016;27(8):2593–2602.
  • Heaney RP, Davies KM, Chen TC, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204–210.
  • Farraye FA, Nimitphong H, Stucchi A, et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis. 2011;17(10):2116–2121.
  • van Groningen L, Opdenoordt S, van Sorge A, et al. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol. 2010;162(4):805–811.
  • Mazahery H, von Hurst P. Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients. 2015;7(7):5111–5142.
  • Ng K, Scott JB, Drake BF, et al. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014;99(3):587–598.
  • Mawer EB, Berry JL, Sommer-Tsilenis E, Beykirch W, et al. Ultraviolet irradiation increases serum 1,25-dihydroxyvitamin D in vitamin-D-replete adults. Miner Electrolyte Metab. 1984;10(2):117–121.
  • Singh G, Bonham AJ. A predictive equation to guide vitamin D replacement dose in patients. J Am Board Fam Med. 2014;27(4):495–509.
  • Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic. Am J Clin Nutr. 2016;103(4):1033–1044.
  • Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit–risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21(7):1121–1132.
  • Feldman D, Pike JW, Bouillon R, et al. Volume 1: Biochemistry, physiology and diagnostics. 4th ed. New York: Academic Press; December 2017, p. 649.
  • Vaes AMM, Tieland M, de Regt MF, et al. Dose–response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: a randomized controlled trial in older adults. Clin Nutr. 2018;37(3):808–814.